0001104659-18-043867.txt : 20180703
0001104659-18-043867.hdr.sgml : 20180703
20180703165658
ACCESSION NUMBER: 0001104659-18-043867
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180601
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Witz Pascale
CENTRAL INDEX KEY: 0001703723
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35587
FILM NUMBER: 18938170
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TESARO, Inc.
CENTRAL INDEX KEY: 0001491576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272249687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (339) 970-0900
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Tesaro, Inc.
DATE OF NAME CHANGE: 20100510
4/A
1
a4a.xml
4/A
X0306
4/A
2018-06-01
2018-06-05
0
0001491576
TESARO, Inc.
TSRO
0001703723
Witz Pascale
C/O TESARO, INC.
1000 WINTER STREET
WALTHAM
MA
02451
1
0
0
0
Common Stock
2018-06-01
4
A
0
1279
0
A
1279
D
Director Nonqualified Stock Option (right to buy)
46.89
2018-06-01
4
A
0
14221
0
A
2028-06-01
Common Stock
14221
14221
D
Director Restricted Stock Units
2018-06-01
4
A
0
8104
0
A
Common Stock
8104
8104
D
The Reporting Person has elected to receive common stock in lieu of cash for board retainers and fees otherwise payable in cash.
The option vests in three annual installments beginning on June 1, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of TESARO common stock.
The RSUs vest in three annual installments beginning on June 1, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors.
This amendment is being filed to amend the Form 4 filed by the reporting person on June 5, 2018 (the "Original Form 4") for the sole purpose of correcting the numbers of derivative securities acquired as reported in column 5 of Table II of the Original Form 4, the numbers of shares underlying securities as reported in column 7 of Table II of the Original Form 4, and the numbers of derivative securities beneficially owned following the reported transactions as reported in column 9 of Table II of the Original Form 4.
/s/ Joseph L. Farmer, Attorney-in-Fact
2018-07-03